Bemcentinib,Pembrolizumab
BerGenBio,Merck
['lcsm,(-blcsm)', 'mesothelioma', 'pembro', 'bemcentinib']
bemcentinib and pembrolizumab in patients with relapsed #mesothelioma: mist3, a phase iia trial with cellular and molecular correlates of efficacy. #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm